The patient would come in with a printout.
You know the one. Pulled from a website you’ve never heard of, about a mechanism you weren’t taught in medical school, asking about a test that isn’t in your standard workup. For a long time, my answer was some version of: I’m not familiar with that, the evidence isn’t there, let’s focus on what we know. Which was the honest answer. It was also, I’ve come to understand, sometimes the incomplete one.
I was a full-time family medicine physician seeing 26 patients a day. I read what my board sent me. I trusted the journals I recognized and filed everything else under noise. That wasn’t laziness. It was survival. Reading outside your lane is a luxury that a full schedule quietly eliminates.
The problem is that the lane keeps getting narrower while the relevant science keeps appearing somewhere else entirely.
The math stopped working
PubMed now contains over 21 million English articles, with more than one million new publications added to biomedicine every single year. Studies show that physicians spend roughly two to three hours per week reading medical journals, almost entirely within their own specialty. The cross-disciplinary research doesn’t make it into the journals most of us subscribe to. The cellular mechanisms mapped by immunologists, the metabolic findings from chronic disease researchers, the autonomic data from cardiologists working on post-viral illness. Almost none of it, and it doesn’t reach clinical guidelines for years.
The frequently cited estimate is that it takes an average of 17 years for research evidence to reach clinical practice. Seventeen years.
What “not in the guidelines yet” actually means
When a physician says something isn’t evidence-based, what they often mean is: It isn’t in the guidelines yet. Those are not the same statement.
A useful example: For decades, graded exercise therapy was the standard recommendation for patients with chronic fatigue conditions. Push through it. Rebuild tolerance. Many physicians are still giving that advice, because it is still what the training said.
The PACE trial supporting exercise therapy was published in 2011. Researchers began challenging its methodology almost immediately. Independent reanalyses using the trial’s own original outcome thresholds found no significant benefit and evidence of harm in the exercise group. The Centers for Disease Control and Prevention (CDC) removed graded exercise therapy from its website recommendations in 2017. The National Institute for Health and Care Excellence (NICE) reversed its guideline in 2021. The American Academy of Family Physicians (AAFP) labeled it an outdated recommendation in 2023. Biological evidence continued to accumulate alongside the guideline changes: Cardiopulmonary exercise testing (CPET) studies show myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) patients demonstrate a significant, reproducible decline in physiological function on repeat exercise testing 24 hours later, a finding that does not occur in healthy sedentary individuals or even patients with severe heart disease. Post-exertional malaise is not deconditioning. It is a measurable biological event.
Patients were being advised to do something harmful for years after the evidence started turning. That is the gap. And it is not unique to this condition. It is structural.
The actual problem
When I left full-time practice and had time to actually read, I went back to primary literature. A paper from a named investigator at a funded academic institution, published in a journal with a real impact factor, replicated by independent labs in multiple countries, is meaningful evidence regardless of whether it has cleared the guidelines pipeline yet. Being in the guidelines is not the same as being true. Not being in the guidelines is not the same as being false.
The wellness industry has done real damage by citing preliminary findings as established clinical guidance. That is a legitimate concern. It is also not the only way patients get hurt by a broken knowledge infrastructure. Patients get hurt when physicians dismiss emerging research entirely because it hasn’t cleared the pipeline yet. They get hurt when we practice with confident familiarity on guidelines that the underlying science has already moved past.
The solution is not more skepticism and it is not less skepticism. It is physicians who still know how to evaluate what the literature actually says: reading primary sources when it matters, checking institutions and replication and conflicts of interest, understanding the difference between a mechanism and a treatment protocol.
Medicine has always had a knowledge lag. What’s different now is the scale. The literature is doubling, the specialties are siloing, and the patients in front of us are not waiting for the 17-year pipeline.
Neither should we.
Alissa Goodwin is a family physician.
